Enhanced cisplatin resistance in oral-cancer stem-like cells is correlated with upregulation of excision-repair cross-complementation group 1

Journal of Dental Sciences

Volumn 7, Issue 2, 2012, Pages 111-117

  Tsai, Lo Lin ^a,b   Yu, Cheng Chia ^a   Lo, Jeng Fan ^c   Sung, Wen Wei ^a   Lee, Huei ^a   Chen, Shiow Ling ^a   Chou, Ming Yung ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

cancer stem cells; chemoresistance; ERCC1; oral squamous cell carcinoma

Indexed keywords

EID: 84862270613     PISSN: 19917902     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jds.2012.03.006     Document Type: Article

References (37)

1. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2008 CA Cancer J Clin 58 2008 71 96
2. M. Pentenero, S. Gandolfo, and M. Carrozzo Importance of tumor thickness and depth of invasion in nodal involvement and prognosis of oral squamous cell carcinoma: a review of the literature Head Neck 27 2005 1080 1091
3. W.L. Lo, S.Y. Kao, L.Y. Chi, Y.K. Wong, and R.C. Chang Outcomes of oral squamous cell carcinoma in Taiwan after surgical therapy: factors affecting survival J Oral Maxillofac Surg 61 2003 751 758
4. P.B. Gupta, C.L. Chaffer, and R.A. Weinberg Cancer stem cells: mirage or reality? Nat Med 15 2009 1010 1012
5. J.M. Rosen, and C.T. Jordan The increasing complexity of the cancer stem cell paradigm Science 324 2009 1670 1673
6. M. Baumann, M. Krause, and R. Hill Exploring the role of cancer stem cells in radioresistance Nat Rev Cancer 8 2008 545 554
7. J.E. Visvader, and G.J. Lindeman Cancer stem cells in solid tumours: accumulating evidence and unresolved questions Nat Rev Cancer 8 2008 755 768
8. M. Dean, T. Fojo, and S. Bates Tumour stem cells and drug resistance Nat Rev Cancer 5 2005 275 284
9. S.H. Chiou, C.C. Yu, and C.Y. Huang Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma Clin Cancer Res 14 2008 4085 4095
10. C.A. Rabik, and M.E. Dolan Molecular mechanisms of resistance and toxicity associated with platinating agents Cancer Treat Rev 33 2007 9 23
11. Z.H. Siddik Cisplatin: mode of cytotoxic action and molecular basis of resistance Oncogene 22 2003 7265 7279
12. V. Cepeda, M.A. Fuertes, J. Castilla, C. Alonso, C. Quevedo, and J.M. Perez Biochemical mechanisms of cisplatin cytotoxicity Anticancer Agents Med Chem 7 2007 3 18
13. C. Cripps, E. Winquist, M.C. Devries, D. Stys-Norman, and R. Gilbert Epidermal growth factor receptor targeted therapy in stages III and IV head and neck cancer Curr Oncol 17 2010 37 48
14. E. Reed Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy Cancer Treat Rev 24 1998 331 344
15. R. Altaha, X. Liang, J.J. Yu, and E. Reed Excision repair cross complementing-group 1: gene expression and platinum resistance Int J Mol Med 14 2004 959 970
16. L.C. Gillet, and O.D. Scharer Molecular mechanisms of mammalian global genome nucleotide excision repair Chem Rev 106 2006 253 276
17. J.T. Reardon, and A. Sancar Nucleotide excision repair Prog Nucleic Acid Res Mol Biol 79 2005 183 235
18. S. Kang, W. Ju, and J.W. Kim Association between excision repair cross-complementation group 1 polymorphism and clinical outcome of platinum-based chemotherapy in patients with epithelial ovarian cancer Exp Mol Med 38 2006 320 324
19. M. Dabholkar, F. Bostick-Bruton, C. Weber, V.A. Bohr, C. Egwuagu, and E. Reed ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients J Natl Cancer Inst 84 1992 1512 1517
20. Y. Shirota, J. Stoehlmacher, and J. Brabender ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy J Clin Oncol 19 2001 4298 4304
21. R. Metzger, C.G. Leichman, and K.D. Danenberg ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy J Clin Oncol 16 1998 309 316
22. R.V. Lord, J. Brabender, and D. Gandara Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer Clin Cancer Res 8 2002 2286 2291
23. K.A. Olaussen, A. Dunant, and P. Fouret DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy N Engl J Med 355 2006 983 991
24. C.E. Hoei-Hansen, S.M. Kraggerud, V.M. Abeler, J. Kaern, E. Rajpert-De Meyts, and R.A. Lothe Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers Mol Cancer 6 2007 12
25. V. Dangles-Marie, M. Pocard, and S. Richon Establishment of human colon cancer cell lines from fresh tumors versus xenografts: comparison of success rate and cell line features Cancer Res 67 2007 398 407
26. M. Todaro, M.P. Alea, and A.B. Di Stefano Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4 Cell Stem Cell 1 2007 389 402
27. D.Y. Wong, K.W. Chang, C.F. Chen, and R.C. Chang Characterization of two new cell lines derived from oral cavity human squamous cell carcinomas-OC1 and OC2 J Oral Maxillofac Surg 48 1990 385 390
28. C.C. Yu, G.Y. Chiou, and Y.Y. Lee Medulloblastoma-derived tumor stem-like cells acquired resistance to TRAIL-induced apoptosis and radiosensitivity Childs Nerv Syst 26 2010 897 904
29. M.J. Wu, C.I. Jan, and Y.G. Tsay Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signaling Mol Cancer 9 2010 283
30. Y.J. Chen, J.T. Chang, and C.T. Liao Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis Cancer Sci 99 2008 1507 1514
31. C.T. Jordan, M.L. Guzman, and M. Noble Cancer stem cells N Engl J Med 355 2006 1253 1261
32. J.C. Wang Evaluating therapeutic efficacy against cancer stem cells: new challenges posed by a new paradigm Cell Stem Cell 1 2007 497 501
33. C.E. Eyler, and J.N. Rich Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis J Clin Oncol 26 2008 2839 2845
34. K.V. Ferry, T.C. Hamilton, and S.W. Johnson Increased nucleotide excision repair in cisplatin-resistant ovarian cancer cells: role of ERCC1-XPF Biochem Pharmacol 60 2000 1305 1313
35. R.A. Britten, D. Liu, A. Tessier, M.J. Hutchison, and D. Murray ERCC1 expression as a molecular marker of cisplatin resistance in human cervical tumor cells Int J Cancer 89 2000 453 457
36. S. Arnould, I. Hennebelle, P. Canal, R. Bugat, and S. Guichard Cellular determinants of oxaliplatin sensitivity in colon cancer cell lines Eur J Cancer 39 2003 112 119
37. M. Selvakumaran, D.A. Pisarcik, R. Bao, A.T. Yeung, and T.C. Hamilton Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines Cancer Res 63 2003 1311 1316